In the present study we evaluated the clinical usefulness of the tumor antigens, squamous
cell carcinoma antigen (SCC) and ovarian carcinoma antigen (CA 125), in populations of …

Serum levels of squamous cell carcinoma antigen SCC, carcinoembryonic antigen CA 125,
and tissue polypeptide antigen were determined in 142 patients with primary cervical …

Serum levels of CA-125 and squamous cell carcinoma-associated antigen (SCC) were
measured in 30 patients with squamous cell carcinoma and 12 patients with …

Serum squamous cell carcinoma antigen (SCCa) concentrations were determined by a
radioimmunoassay kit before and during the treatment of 50 patients with cervical …

SUMMARY Between 1978 and 1987, 439 patients with primary cervical carcinoma were
admitted to our department. Seventy-seven patients (17.5%) had cervical adenocarcinoma …

The prognostic value of the pretreatment serum CA 125, squamous cell carcinoma antigen
(SCC), and carcinoembryonic antigen (CEA) levels in relation to tumor type, vascular …

Our objective was to evaluate the diagnostic value of squamous cell carcinoma antigen
(SCC-ag) and cancer antigen (CA) 125 serum tumor markers for the detection of cervical …

A review is given of the clinical use and interpretation of serum tumor marker levels during
the treatment of patients with cancer of the uterine cervix. Pretreatment serum squamous cell …

CA125 (reference value [RV]= 35 U/mL), CA50 (RV= 20 U/mL), CA72. 4 (RV= 3.8 U/mL) and
SCC (RV= 3.6 ng/mL) levels were retrospectively assayed in blood samples collected at …

Serum levels of carcinoembryonic antigen (CEA) and cancer antigens CA 125 and CA 19.9
were determined by immunoradiometric assay in 96 patients diagnosed of invasive …